The combination of Everolimus with Verapamil reduces ovarian weight and vascular permeability on ovarian hyperstimulation syndrome: a preclinical experimental randomized controlled study-Reference-Cited by-同舟云学术

The combination of Everolimus with Verapamil reduces ovarian weight and vascular permeability on ovarian hyperstimulation syndrome: a preclinical experimental randomized controlled study

Published:2016-05-25 Issue:11 Volume:32 Page:886-890
ISSN:0951-3590
Container-title:Gynecological Endocrinology
language:en
Short-container-title:Gynecological Endocrinology

Author:

Kitsou Chrysoula¹,Kosmas Ioannis²³,Lazaros Leandros¹,Tzallas Christos⁴,Tinelli Andrea³⁵,Mynbaev Ospan³,Prapas Nikolaos⁶,Prapas Ioannis⁶,Dalkalitsis Alexandros¹,Georgiou Ioannis¹

Affiliation:

1. Department of Obstetrics and Gynecology, Genetics and IVF Unit, Medical School, Ioannina University, Ioannina, Greece,

2. Department of Obstetrics and Gynecology, Ioannina State General Hospital G. Chatzikosta, Ioannina, Greece,

3. The International Translational Medicine and Biomodeling Research Team, Laboratory of Molecular and Cellular Technologies, MIPT Center for Human Physiology Studies, Moscow Institute of Physics and Technology, Dolgoprudny, Russia,

4. Laboratory of Biochemistry, Ioannina University Hospital, Ioannina, Greece,

5. Department of Obstetrics and Gynecology, Division of Experimental Endoscopic Surgery, Imaging, Minimally Invasive Therapy and Technology, Vito Fazzi Hospital, Lecce, Italy, and

6. Iakentro IVF Center, Thessaloniki, Greece

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.1080/09513590.2016.1188376

Reference20 articles.

1. Everolimus, an mTOR pathway inhibitor, is highly successful on ovarian hyperstimulation syndrome by reducing ovarian weight and progesterone levels: a preclinical experimental randomized controlled study

2. Ovarian hyperstimulation syndrome inhibition by targeting VEGF, COX-2 and Calcium pathways: a preclinical randomized study

3. Pharmacokinetic interaction between verapamil and everolimus in healthy subjects

4. Mechanisms of malignant ascites production

5. Vascular Endothelial Growth Factor Receptor-2 Activation Induces Vascular Permeability in Hyperstimulated Rats, and this Effect Is Prevented by Receptor Blockade

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of GnRH-antagonist, mifepristone and letrozole on preventing ovarian hyperstimulation syndrome in rat model;Reproductive BioMedicine Online;2021-02

2. Follicle inhibition at the primordial stage without increasing apoptosis, with a combination of everolimus, verapamil;Molecular Biology Reports;2020-10-20

3. Successful reversal of ovarian hyperstimulation syndrome in a mouse model by rapamycin, an mTOR pathway inhibitor;Molecular Human Reproduction;2019-07-22